FHL2: a scaffold protein of carcinogenesis, tumour-stroma interactions and treatment response.

Verset, Laurine; Feys, Lynn; Trépant, Anne-Laure; De Wever, Olivier; Demetter, Pieter

Verset, Laurine; Feys, Lynn; Trépant, Anne-Laure; De Wever, Olivier; Demetter, Pieter.

Afiliación

Verset L; Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Feys L; Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University, Ghent, Belgium.
Trépant AL; Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
De Wever O; Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University, Ghent, Belgium.
Demetter P; Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium. pieter.demetter@erasme.ulb.ac.be.

Histol Histopathol ; 31(5): 469-78, 2016 May.

Article en En | MEDLINE | ID: mdl-26676939

Asunto(s)

Carcinogénesis/metabolismo; Neoplasias Gastrointestinales/metabolismo; Proteínas con Homeodominio LIM/metabolismo; Proteínas Musculares/metabolismo; Factores de Transcripción/metabolismo; Animales; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas con Homeodominio LIM / Carcinogénesis / Neoplasias Gastrointestinales / Proteínas Musculares Límite: Animals / Humans Idioma: En Revista: Histol Histopathol Asunto de la revista: HISTOLOGIA / PATOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google